Continuum Advisory’s Firefly Neuroscience AIFF Stock Holding History
Bought
Maintained
Sold
Other funds holding AIFF
M
BFM
CCA
Continuum Advisory's AIFF Position: Q2 2026 in Review
Continuum Advisory opened a new position in Firefly Neuroscience (AIFF) in Q2 2026: 1 share worth $1. The stake represents ﹤0.01% of the portfolio and ranks #1986 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in AIFF as recently as Q1 2025.
Continuum Advisory first reported a position in AIFF in Q3 2024 and has held it in 4 quarters since. The position peaked at $73 in Q3 2024. 23 funds tracked by Wall St. Rank hold AIFF as of Q2 2026.
- Continuum Advisory held 1 share of Firefly Neuroscience worth $1 as of Q2 2026.
- Firefly Neuroscience was a new Continuum Advisory position in Q2 2026.
- Firefly Neuroscience made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1986 holding.
- Continuum Advisory first reported a position in Firefly Neuroscience in Q3 2024 and has held it in 4 quarters since.
- Continuum Advisory's Firefly Neuroscience position peaked at $73 in Q3 2024.
- 23 funds tracked by Wall St. Rank held Firefly Neuroscience as of Q2 2026.
Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.